Assay development in leishmaniasis drug discovery: a comprehensive review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Assay development in leishmaniasis drug discovery: a comprehensive review

Published:2021-11-24 Issue:2 Volume:17 Page:151-166
ISSN:1746-0441
Container-title:Expert Opinion on Drug Discovery
language:en
Short-container-title:Expert Opinion on Drug Discovery

Author:

Zulfiqar Bilal¹^ORCID,Avery Vicky. M.¹²³

Affiliation:

1. Discovery Biology, Griffith University, Brisbane, Australia

2. Discovery Biology, Griffith University Drug Discovery Programme for Cancer Therapeutics, Brisbane, Australia

3. School of Environment and Sciences, Griffith University, Brisbane, Australia

Funder

Drugs for Neglected Diseases Initiative

Publisher

Informa UK Limited

Subject

Drug Discovery

Link

https://www.tandfonline.com/doi/pdf/10.1080/17460441.2022.2002843

Reference139 articles.

1. Post kala-azar dermal leishmaniasis: A threat to elimination program

2. WHO. Leishmaniasis fact sheet 2020 Accessed 7 April 2021. Available from: https://www.who.int/en/news-room/fact-sheets/detail/leishmaniasis

3. The current status of zoonotic leishmaniases and approaches to disease control

4. Leishmaniaspp: Temperature Sensitivity of Promastigotesin Vitroas a Model for Tropismin Vivo

5. The immunological, environmental, and phylogenetic perpetrators of metastatic leishmaniasis

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathophysiology of Leishmaniasis;Egyptian Journal of Veterinary Sciences;2025-01-01

2. Antiprotozoal potential of Vismia species (Hypericaceae), medicinal plants used to fight cutaneous leishmaniasis;Journal of Ethnopharmacology;2024-06

3. A review on potential therapeutic targets for the treatment of leishmaniasis;Parasitology International;2024-06

4. Antileishmanial effect of podophyllotoxin and podophyllin on Leishmania major in vitro and in vivo;Journal of Parasitic Diseases;2024-02-25

5. The association between rLiHyp1 protein plus adjuvant and amphotericin B is an effective immunotherapy against visceral leishmaniasis in mice;Acta Tropica;2023-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3